Desk›Healthcare› Alkem Laboratories Ltd
Alkem Laboratories Ltd
BSE 539523 · NSE ALKEM · ISIN INE540L01014 · Group A · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹5,350.15
+0.67%
BSE close, 28 August 2026
₹63,969.07 cr
12.0 cr shares · Mid cap
₹31,379.77 cr
as published
29.1× · 5.43×
EPS ₹183.66 · BV ₹985.29
9,663.91 / 2,282.09
₹ cr, as filed
29
11 selected · 38%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -9.8% |
|---|---|
| Against 52-week low | +5.2% |
| Day change | +0.67% |
| Size band | Mid cap |
| Index membership | NIFTY 500 |
Valuation as published by BSE
| Earnings per share | ₹183.66 |
|---|---|
| Price / earnings | 29.13× |
| Price / book | 5.43× |
| Book value — derived, price ÷ P/B | ₹985.29 |
| Return on equity | 18.66% |
| Operating margin | 32.73% |
| Net margin | 21.37% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 18.64%
- ROE as published
- 18.66%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 2,667.73 | 569.98 | 47.67 | 32.73% | 21.37% |
| Mar-26 · Q | 2,258.44 | 217.06 | 18.16 | 19.06% | 9.61% |
| FY25-26 | 9,663.91 | 2,282.09 | 182.76 | 29.35% | 23.61% |
Quarter on quarter
- Revenue, quarter on quarter
- +18.1%
- Net profit, quarter on quarter
- +162.6%
- Operating margin, quarter on quarter
- +1,367 bps
Disclosure profile 29 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Change in Management | 3 |
| Concall Transcript | 2 |
| Press Release | 2 |
| Board Outcome | 1 |
| Investor Presentation | 1 |
| KMP | 1 |
| Results | 1 |
| Selected sub-total | 11 |
| Procedural | |
| General | 4 |
| AGM / EGM | 3 |
| Analyst / Investor Meet | 3 |
| Trading Window | 2 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Court Convened Meeting | 1 |
| Newspaper Publication | 1 |
| SAST | 1 |
| Procedural sub-total | 18 |
| Total | 29 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
29 filings · 11 selected · busiest 2026-08-14
Filing rhythm · the twelve most recent
2026-08-202026-09-24
SelectedProcedural
Filings
29 in the window · 14 earlier on record
-
24 September 2026 ·
Cessation
Please find attached herewith intimation for change in Key Managerial Personnel - Resignation of Chief Financial Officer
Company Update / Cessation View filing →
-
23 September 2026 ·
Analyst / Investor Meet - Intimation
Please find attached herewith intimation of Schedule of Analyst / Institutional Investor Meeting.
Company Update / Analyst / Investor Meet View filing →
-
22 September 2026 ·
Closure of Trading Window
Please find attached herewith intimation for closure of trading window.
Insider Trading / SAST / Closure of Trading Window View filing →
-
21 September 2026 ·
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations
Please find attached herewith intimation for issue of corporate guarantee by the Company.
Company Update / General View filing →
-
16 September 2026 ·
Press Release / Media Release
Alkem Laboratories Limited launches NeuCeno (cenobamate) for the treatment of partial - onset seizures in adult patients.
Company Update / Press Release / Media Release View filing →
-
15 September 2026 ·
Change in Management
Please find attached herewith intimation for appointment of Dr. Shubhadeep Sinha as Senior Management Personnel of the Company.
Company Update / Change in Management View filing →
-
8 September 2026 ·
Press Release / Media Release
Alkem Laboratories Limited launches Renocia ExoTM, India's first patented Ginsenoside Exosome - based hair growth serum
Company Update / Press Release / Media Release View filing →
-
27 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Please find attached herewith Scrutinizer Report for 52nd Annual General Meeting of the Company.
AGM/EGM / AGM View filing →
-
27 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Please find attached herewith Outcome of the 52nd Annual General Meeting of the Company and disclosure of voting results thereat.
AGM/EGM / AGM View filing →
-
26 August 2026 ·
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Mutual Fund
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
20 August 2026 ·
Earnings Call Transcript
Please find attached herewith Q1 FY27- Earnings Call Transcript.
Company Update / Earnings Call Transcript View filing →
-
20 August 2026 ·
Earnings Call Transcript
Please find attached herewith Q1 FY27- Earnings Call Transcript.
Company Update / Earnings Call Transcript View filing →
-
17 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting
Please find attached herewith Proceedings of the meeting of the equity shareholders of the Company and Scrutinizer's Report on e-voting.
AGM/EGM / Court Convened Meeting View filing →
-
14 August 2026 ·
Analyst / Investor Meet - Outcome
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the ' Q1FY27 Earnings Conference Call' is available ....
Company Update / Analyst / Investor Meet View filing →
-
14 August 2026 ·
Closure of Trading Window
The Financials Results of the Company for the quarter ended 30th June, 2026 having been communicated to the Stock Exchanges today ie 14th Aug the trading window shall open on 17th Aug, 2026.
Insider Trading / SAST / Closure of Trading Window View filing →
-
14 August 2026 ·
Investor Presentation
Pl find enclosed press release and analyst presentation on Q1FY27 earnings and business updates of the Company
Company Update / Investor Presentation View filing →
-
14 August 2026 ·
Announcement Under Reg 30 (LODR)
Pl find attached herewith intimation under Reg 30
Company Update / General View filing →
-
14 August 2026 ·
Results- Unaudited Financial Results For Quarter Ended June 30, 2026
Pl find enclosed unaudited financial results along with LRR for quarter ended 30th June, 2026
Result / Financial Results View filing →
-
14 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Dated 14/08/2026
Please find enclosed herewith the outcome of Board meeting dated 14th Aug, 2026. The meeting of the Board of Directors of the Company commenced at 11 am and concluded at 13.40 pm. Kindly take the same
Board Meeting / Outcome of Board Meeting View filing →
-
6 August 2026 ·
Update On US FDA Inspection At Company'S Manufacturing Facility Located At Amaliya, Daman
Please find attached herewith intimation about update on US FDA inspection at Company's Manufacturing Facility Located at Amaliya, Daman.
Company Update / General View filing →
-
3 August 2026 ·
Change in Management
Please find attached herewith regarding Appointment of Senior Management Personnel.
Company Update / Change in Management View filing →
-
30 July 2026 ·
Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find attached herewith Disclosure under Regulation 30 of the SEBI (LODR) Regulation 2015.
Company Update / General View filing →
-
30 July 2026 ·
Newspaper Publication
Please find attached herewith a copy Newspaper Publication.
Company Update / Newspaper Publication View filing →
-
29 July 2026 ·
Notice Of 52Nd Annual General Meeting And Annual Report For FY 2025-26.
Please find attached herewith the Notice of AGM alongwith the Annual Report for the FY 2025-2026.
AGM/EGM / AGM View filing →
-
29 July 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
Please find attached herewith the Business Responsibility and Sustainability Report for the financial year ended 31st March, 2026.
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
29 July 2026 ·
Reg. 34 (1) Annual Report.
Please find enclosed herewith the Notice of the 52nd Annual General Meeting of the Company scheduled to be held on Thursday, 27th August, 2026 at 11.00 a.m. through Video Conferencing (VC)/ ....
Others / Reg. 34 (1) Annual Report View filing →
-
27 July 2026 ·
Analyst / Investor Meet - Intimation
Please find attached herewith intimation for Analyst / Investor Meet.
Company Update / Analyst / Investor Meet View filing →
-
23 July 2026 ·
Change in Management
Please find attached herewith Intimation regarding Resignation of Senior Management Personnel.
Company Update / Change in Management View filing →
-
21 July 2026 ·
Board Meeting Intimation for Notice Of Meeting Of The Board Of Directors Of The Company.
Alkem Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Please find attached herewith ....
Board Meeting / Board Meeting View filing →
RSS feed for Alkem Laboratories Ltd · the 50 most recent filings